BioCentury
ARTICLE | Clinical News

Dexosome-based cancer vaccine: Phase I

October 28, 2002 8:00 AM UTC

In a French Phase I study in 6 patients with stage III or IV melanoma treated with the vaccine, 2 patients had prolonged disease stabilization and 1 patient had tumor shrinkage. A CTL response was det...